shortagewatch

Home / Companies / Sterimax

Company family

Sterimax: medicine shortages

As of 2 Nov 2026, 26 Sterimax products have a reported shortage across 2 countries, covering 17 medicines.

Products short26rank #81 of 464
Medicines17active ingredients
Countries2/16
New in 90 days1-5 vs market pace
Typical duration6.3 yearsmedian so far
Manufacturing13%demand-driven 26%

Where

United States3Canada23

Which therapeutic classes

Anti-infectives9Cancer and immune system4Nervous system4Blood3Systemic hormones2Sensory organs1Digestive tract and metabolism1Dermatologicals1Cardiovascular system1

Why, compared with all companies

Manufacturing problemIncreased demandActive ingredient shortageDistribution or logisticsCommercial decision or withdrawalRegulatory or licensingOtherNot stated
SterimaxSterimax: Manufacturing problem 3 (12%)12%Sterimax: Increased demand 6 (23%)23%Sterimax: Distribution or logistics 5 (19%)19%Sterimax: Other 9 (35%)35%Sterimax: Not stated 3 (12%)12%All companiesAll companies: Manufacturing problem 4,893 (36%)36%All companies: Increased demand 1,873 (14%)14%All companies: Active ingredient shortage 367 (3%)All companies: Distribution or logistics 336 (2%)All companies: Commercial decision or withdrawal 435 (3%)All companies: Regulatory or licensing 131 (1%)All companies: Other 1,244 (9%)9%All companies: Not stated 4,221 (31%)31%

Manufacturing problems point to the company's own supply chain; increased demand often follows a competitor's shortage or a demand shock.

Latest changes

All changes

No changes recorded yet. Changes are tracked from our daily snapshots.

When its current shortages began

01235Dec: 0Jan ’25: 0Feb: 0FebMar: 0Apr: 0May: 0MayJun: 0Jul: 0Aug: 1AugSep: 0Oct: 0Nov: 0NovDec: 0Jan ’26: 0Feb: 3FebMar: 0Apr: 0May: 0MayJun: 2Jul: 1Aug: 0AugSep: 0Oct: 1Nov: 0Nov

Long-run trend in Canada

Canada dashboard
0122537502017: 1420172018: 1320182019: 2020192020: 3220202021: 420212022: 1720222023: 1520232024: 3920242025: 1520252026: 172026

Canada publishes every report since 2017, so it shows whether this company is reporting more or fewer shortages over time. The current year is partial.

Against its peers

Viatris995Teva903Sandoz599Pfizer491Accord (Intas)484Stada349Zentiva340Fresenius Kabi339Apotex326Sun Pharma250Aurobindo226Towa (Pensa)201Krka187Sanofi158Sterimax26

Breadth vs depth

1101001,00010,0001101001,000Products short (log scale)Medicines affected (log scale)Viatris: 995 / 248ViatrisTeva: 903 / 289TevaSandoz: 599 / 198SandozPfizer: 491 / 122PfizerAccord (Intas): 484 / 151Accord (Intas)Stada: 349 / 140Zentiva: 340 / 159ZentivaFresenius Kabi: 339 / 81Apotex: 326 / 152Sun Pharma: 250 / 77Aurobindo: 226 / 111Towa (Pensa): 201 / 102Krka: 187 / 67Sanofi: 158 / 45Jamp: 151 / 74Baxter: 149 / 27Sawai: 148 / 68Hikma: 126 / 44Glenmark: 105 / 39Sanis: 98 / 54Cheplapharm: 86 / 28GSK: 85 / 38Advanz (Amdipharm): 81 / 24Nichi-Iko: 77 / 29Takeda: 76 / 10Johnson & Johnson: 75 / 19Neuraxpharm: 75 / 19Novartis: 70 / 32Bayer: 68 / 17Biomed: 64 / 21Daiichi Sankyo: 59 / 18Orifarm: 59 / 40Medochemie: 56 / 14Pharmascience: 51 / 32Marcan: 51 / 16Doc Generici: 50 / 25B. Braun: 49 / 17AA Pharma: 46 / 26H E: 46 / 15Octapharma: 42 / 6Jv E: 42 / 1Kyowa Pharmaceutical: 42 / 16Novo Nordisk: 41 / 8Odan: 41 / 31Aspen: 41 / 13Sterop: 41 / 16Nipro: 41 / 17Dr. Reddy's: 40 / 24Organon: 40 / 20Laboratoire Riva: 40 / 23Kern Pharma: 40 / 30Bausch Health: 39 / 30Bracco: 38 / 6G.L.: 38 / 13Tatsumi Kagaku: 38 / 24Otsuka: 37 / 4Eli Lilly: 37 / 12Piramal Critical: 35 / 13Imuna Pharm: 35 / 4AbbVie: 34 / 15Medical Valley: 34 / 8Orion: 34 / 24Rowex: 34 / 19Takata Pharmaceutical: 33 / 17Aristo: 32 / 16Norgine: 32 / 3Gedeon Richter: 31 / 11Eql: 31 / 9Guerbet: 30 / 5Lukas Heil-Betriebsst: 30 / 0Roche: 29 / 14Omega: 29 / 18Bgp: 29 / 18Holsten -: 29 / 3Menarini: 29 / 17Paladin: 28 / 17Grifols: 28 / 9Ge: 28 / 6Merck & Co. (MSD): 27 / 14Ferring: 27 / 7Sterimax: 26 / 17Sterimax

Further right: more products short. Higher: more different medicines affected.

Medicines short

Download CSV
MedicineWhere this company is shortProductsEarliest startMain reasonShort anywhere
Cefuroxime331 Mar 2020Other5/16
Tranexamic Acid320 Apr 2020Increased demand10/16
Aciclovir216 Jun 2020Distribution or logistics6/16
Cefotaxime217 Feb 2015Not stated7/16
Cyclophosphamide220 Feb 2026Increased demand12/16
Hydromorphone231 Jul 2026Distribution or logistics5/16
Triamcinolone227 Aug 2025Increased demand8/16
Acetazolamide11 Jun 2024Other2/16
Calcitriol11 Jun 2024Manufacturing problem6/16
Ciclopirox17 Apr 2017Other3/16
Hydralazine121 Aug 2019Other5/16
Ifosfamide112 Jun 2026Not stated12/16
Paclitaxel129 Sep 2014Other7/16
Pilocarpine116 Apr 2015Other2/16
Polymyxin B117 Jan 2017Other1/16
Sufentanil125 Jun 2026Manufacturing problem6/16
Tobramycin15 Feb 2018Distribution or logistics5/16

Shortage data describes supply, not company finances. A shortage can mean lost sales for the supplier or extra demand for its competitors. Nothing here is investment advice; tickers are for identification only and may be out of date.